S1126 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study. (October 2020) - Bae, Ho S.; Lim, Young-Suk; Trinh, Huy; Heo, Jeong; Chuang, Wan-Long; Hui, Aric Josun; Elkhashab, Magdy; Tan, Susanna K.; Mo, Shuyuan; Guion, Matthew; Jump, Belinda; Flaherty, John; et al.